News & Updates

A recent first-in-human study has shown that directly applying pembrolizumab to the bladder is a safe and effective treatment option for patients with nonmuscle-invasive bladder cancer (NMIBC) who are unresponsive to bacillus Calmette-Guérin (BCG) treatment.

Hypertensive patients who work shifts face an increased risk of developing more than two cardiometabolic diseases or cardiometabolic multimorbidity, according to a study.

Patients with diabetes mellitus (DM) who also have atrial fibrillation (AF) are at a heightened risk of developing end-stage renal disease (ESRD), a recent study has found.

In patients with knee osteoarthritis (OA), walking as a form of exercise may prevent the development of knee pain, a study has found.

Trabectedin did not improve overall survival (OS) or progression-free survival (PFS) compared with chemotherapy in women with recurrent ovarian, primary peritoneal, or fallopian tube cancer and BRCA mutation or BRCAness phenotypes, according to results of the phase III MITO23 trial.